Serum Endocan, Alarin, and Galanin-Like Peptide Levels in Diabetic Retinopathy
Clinical trial NCT07434362 · COMPLETED
Trial details
- NCT number
- NCT07434362
- Sponsor
- Elazıg Fethi Sekin Sehir Hastanesi
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-30
- Primary completion
- 2026-02-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.